Enzo Biochem, Inc. operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzo Biochem with three other pharmaceutical manufacturers in North America: OrganiGram Holdings Inc of Canada (2019 sales of 80.41 million Canadian Dollars [US$60.64 million] ), Palatin Technologies, Inc. ($60.30 million of which 100% was Licenses, Grants and Contracts), and Summit Therapeutics PLC ($56.84 million of which 100% was Drug Discovery).

Sales Analysis. During the year ended July of 2019, sales at Enzo Biochem were $81.17 million. This is a decrease of 22.5% versus 2018, when the company's sales were $104.71 million. Contributing to the drop in overall sales was the 31.6% decline in Clinical Laboratory Services, from $74.78 million to $51.12 million. . However, these declines were partially offset by the increase in sales of Life Sciences Products (up 0.4% to $30.06 million) .